Moreover, approximately 25% of these mice eventually developed mammary tumors by approximately 1.5 years of age, and the tumorigenesis was markedly enhanced when a heterozygous mutation of p53 was introduced into these mice (Brca1-MSK p53+/–) (8–10). Here, TP53 is linked to breast cancer.